小儿支气管肺炎治疗方法及相关免疫机制的研究进展  

Research on the treatment of bronchopneumonia in children and related immune mechanisms

作　　者：利荣乔 梁庆华[1] 黄盼柳 黄智华 罗淋尹 LI Rongqiao;LIANG Qinghua;HUANG Panliu;HUANG Zhihua;LUO Linyin(Department of Clinical Laboratory,Jiangbin Hospital,Guangxi Zhuang Autonomous Region Nanning,Guangxi 530021,China)

机构地区：[1]广西壮族自治区江滨医院检验科,广西南宁530021

出　　处：《医药前沿》2022年第18期34-36,共3页Journal of Frontiers of Medicine

基　　金：广西壮族自治区卫生健康委员会自筹经费科研课题《头孢曲松联合三联雾化治疗小儿支气管肺炎的免疫检验指标分析》(Z20211094)。

摘　　要：支气管肺炎是一种常见的儿童传染病,我国小儿支气管肺炎发病率较高。本研究通过对小儿支气管肺炎的发展趋势、国内外研究现状进行综述,并对相关免疫机制的研究进行分析,小儿支气管肺炎的发病因素主要与炎性因子相关,目前临床上的中医、西医甚至是中西医结合的治疗方法均存在一定的缺陷,仍需要进行进一步探讨小儿支气管肺炎的最佳治疗方案。This study introduced the current research situation of children’s bronchial pneumonia at home and abroad,briefly described its development trend,reviewed the existing problems,analyzed the related immune mechanism research,and concluded that at present,there are still disadvantages in clinical treatment of children’s bronchial pneumonia,and at the same time,we should improve children’s own immunity,strengthen their physique and resist diseases while exploring the best treatment scheme.

关 键 词：综述 小儿支气管肺炎 治疗方案 免疫机制 

分 类 号：R563.1[医药卫生—呼吸系统]